Sign in

CIK 0001368514 · Large accelerated filer

ADMA BIOLOGICS, INC.

Sign in to watch
Ticker
ADMA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
562590442
Phone
(201) 478-5552
Business address
C/O ADMA BIOLOGICS, INC., 465 STATE ROUTE 17, RAMSEY, NJ, 07446
Former names
R&R ACQUISITION VI, INC
  1. 4 Open-market sale Director sold 9,000 shares at an average $20.29 ($182,636)
  2. 4 Planned sale President and CEO sold 21,000 shares at $19.45 ($408,450)
  3. 4 Planned sale President and CEO sold 21,000 shares at $21.46 ($450,660)
  4. 4 Shares withheld for taxes COO and SVP, Compliance gave up 18,920 shares (to pay taxes)
  5. 4 Planned sale President and CEO sold 21,000 shares at $18.92 ($397,320)
  6. 4 Shares withheld for taxes President and CEO gave up 85,951 shares (to pay taxes)
  7. 4 Shares withheld for taxes COO and SVP, Compliance gave up 12,816 shares (to pay taxes)
  8. 4 Shares withheld for taxes President and CEO gave up 72,885 shares (to pay taxes)
  9. 4 Shares withheld for taxes COO and SVP, Compliance gave up 1,855 shares (to pay taxes)
  10. 4 Shares withheld for taxes CFO and Treasurer gave up 5,280 shares (to pay taxes)
  11. 4 Grant or award Director acquired 10,889 shares (grant or award)
  12. 4 Grant or award Director acquired 10,889 shares (grant or award)
  13. 4 Grant or award Director acquired 10,889 shares (grant or award)
  14. 4 Grant or award Director acquired 10,889 shares (grant or award)
  15. 4 Grant or award Director acquired 10,889 shares (grant or award)
  16. 4 Grant or award Director acquired 10,889 shares (grant or award)
  17. 4 Grant or award CFO and Treasurer acquired 62,227 shares (grant or award)
  18. 4 Grant or award COO and SVP, Compliance acquired 77,784 shares (grant or award)
  19. 4 Grant or award President and CEO acquired 252,022 shares (grant or award)
  20. 4 Shares withheld for taxes COO and SVP, Compliance gave up 3,355 shares (to pay taxes)

Page 3 of 19 · 362 filings